Functional genomics: paving the way for more successful cancer immunotherapy

被引：6

作者：

Ajina, Reham ^{[1
]}

Zamalin, Danielle ^{[2
]}

Weiner, Louis M. ^{[3
,4
,5
]}

机构：

[1] Georgetown Univ, Tumor Biol, Washington, DC 20057 USA

[2] Georgetown Univ, Washington, DC 20057 USA

[3] Georgetown Univ, Georgetown Lombardi Comprehens Canc Ctr LCCC, Washington, DC 20057 USA

[4] Dept Oncol, Washington, DC USA

[5] MedStar Georgetown Canc Inst, Washington, DC USA

来源：

BRIEFINGS IN FUNCTIONAL GENOMICS | 2019年 / 18卷 / 02期

关键词：

cancer; functional genomics; immunotherapy; checkpoints; immunity; T-CELL-RECEPTOR; CLONAL EXPANSION; PD-L1; EXPRESSION; OPEN-LABEL; TUMOR; IPILIMUMAB; RESISTANCE; MECHANISMS; BLOCKADE; PEMBROLIZUMAB;

D O I：

10.1093/bfgp/ely017

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Immunotherapies have revolutionized cancer treatment. Immunotherapy is effective for the treatment of a wide range of cancer types and can mediate complete and durable tumor regression. Nonetheless, the field still faces many significant challenges, such as the need for personalized therapeutic strategies and better biomarkers, the difficulty of selecting the right combination therapy, and resistance to currently available immunotherapies. Both cancer and host immunity comprise significantly diverse and complex ecosystems, making immunogenomics an ideal field for functional genomics analysis. In this review, we describe the cancer-immunity cycle, how cancer cells manage to evade immune attack and the current hurdles in the path of cancer immunotherapy. Then, we discuss how functional genomics approaches can pave the way for more successful cancer immunotherapies.

引用

页码：86 / 98

页数：13

共 50 条

[21] Paving the Way toward Successful Multiple Myeloma Treatment: Chimeric Antigen Receptor T-Cell Therapy
Grywalska, Ewelina
Sosnowska-Pasiarska, Barbara
Smok-Kalwat, Jolanta
Pasiarski, Marcin
Niedzwiedzka-Rystwej, Paulina
Rolinski, Jacek
CELLS, 2020, 9 (04)
[22] Immunogenomics: using genomics to personalize cancer immunotherapy
Rance C. Siniard
Shuko Harada
Virchows Archiv, 2017, 471 : 209 - 219
[23] Case Report: Successful Immunotherapy Improved the Prognosis of the Unfavorable Subset of Cancer of Unknown Primary
Mei, Jie
Wang, Hao
Fan, Honghong
Ding, Junli
Xu, Junying
FRONTIERS IN IMMUNOLOGY, 2022, 13
[24] Paving Way for a Paradigm Shift in Oncology: Curing Cancer by Loving It?
Uskokovic, Vuk
MICRO-SWITZERLAND, 2023, 3 (03): : 749 - 762
[25] Functional Genomics for Cancer Research: Applications In Vivo and In Vitro
O'Loughlin, Thomas A.
Gilbert, Luke A.
ANNUAL REVIEW OF CANCER BIOLOGY, VOL 3, 2019, 3 : 345 - 363
[26] Decoding functional impact of epigenetic regulator mutations on ligand-receptor interaction perturbations for evaluation of cancer immunotherapy
Shi, Aiai
Lin, Chaohuan
Lyu, Jie
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (18)
[27] Immune checkpoint blockade opens a new way to cancer immunotherapy
Sadreddini, Sanam
Baradaran, Behzad
Aghebati-Maleki, Ali
Sadreddini, Sevil
Shanehbandi, Dariush
Fotouhi, Ali
Aghebati-Maleki, Leili
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (06) : 8541 - 8549
[28] Successful Use of Immunotherapy in a Patient with Metastatic Squamous Cell Lung Cancer and Underlying Autoimmune Disease
Zakharian, Lusine
Lee, Lauren
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
[29] Lipid metabolism alterations and ferroptosis in cancer: Paving the way for solving cancer resistance
Lee, Jaewang
Shin, Daiha
Roh, Jong-Lyel
EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 941
[30] The Era of Immunotherapy in Small-Cell Lung Cancer: More Shadows Than Light?
Rossi, Sabrina
Pagliaro, Arianna
Michelini, Angelica
Navarria, Pierina
Clerici, Elena
Franceschini, Davide
Toschi, Luca
Finocchiaro, Giovanna
Scorsetti, Marta
Santoro, Armando
CANCERS, 2023, 15 (24)

← 1 2 3 4 5 →